市場調査レポート

商品コード

1801168

腸疾患検査の市場規模、シェア、動向、予測：製品タイプ、手法、疾患タイプ、エンドユーザー、地域別、2025～2033年

Enteric Disease Testing Market Size, Share, Trends and Forecast by Product Type, Technique, Disease Type, End User, and Region, 2025-2033

出版日: 2025年08月01日
発行: IMARC
ページ情報: 英文 124 Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF & Excel (Single User License)

USD 2,999 447,600円

レポートPDFおよびExcelを1名のみがご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピー&ペースト、印刷はできません。

PDF & Excel (5 User License)

USD 3,999 596,850円

レポートPDFおよびExcelを同一企業内の5名様までがご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピー&ペーストはできませんが、印刷は5部まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Corporate License)

USD 4,999 746,100円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピー&ペーストは可能ですが、事前にIMARC Services Private Limited社の許可が必要です。PDFおよびExcelの印刷回数に制限はありません。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=149.25円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

腸疾患検査の世界市場規模は、2024年に43億1,000万米ドルとなりました。今後、IMARC Groupは、同市場が2033年までに56億4,000万米ドルに達し、2025年から2033年にかけて2.90％のCAGRを示すと予測しています。現在、アジア太平洋地域が市場を独占しており、2024年の市場シェアは38.8％を超えています。腸疾患検査市場のシェアは、消化器感染症の発生率の増加、早期診断に対する意識の高まり、診断技術の進歩、より迅速で正確な検査方法に対する需要の高まり、食品と水の安全基準に対する世界の関心の高まりによって拡大しています。

腸疾患検査市場の成長は、消化管感染症や食中毒の増加、診断技術の開発により増加しています。細菌、ウイルス、寄生虫によって引き起こされる腸管疾患は、世界中で数百万人が罹患し、重篤な下痢、脱水、その他の合併症を引き起こしています。迅速で正確、かつ費用対効果の高い診断ソリューションに対する需要の高まりが、市場の拡大に拍車をかけています。食品の安全性に対する意識の高まりと、PCRやイムノアッセイのような分子診断と相まって、疾病監視に向けた政府の取り組みが、診断企業の需要を後押ししています。診断企業は、ヘルスケア分野の技術的アップグレードに助けられ、より迅速で、信頼性が高く、迅速な検査ソリューションに多額の投資を始めています。検査室における自動化の推進は、ポイントオブケア検査キットとともに市場を前進させています。さらに、研究センターとヘルスケア機関の提携により、診断製品がより入手しやすくなっています。さらに、早期かつ正確な診断に対する需要の高まりは、アウトブレイクの抑制と予防に重要な要素である腸疾患検査市場の動向に影響を与え続けるであろう。

米国は腸疾患検査の主要な地域市場として浮上しており、食中毒患者の増加、消化器感染症に対する認識、診断技術の進歩がその原動力となっています。PCRやイムノアッセイを含む分子診断法は、正確で迅速な結果が得られることから人気を集めています。政府の取り組み、例えばFDAの食品安全近代化法（FSMA）は、予防対策と早期発見に重点を置くことで市場の需要をさらに押し上げています。病院、診断ラボ、ポイントオブケア検査施設は、診断の自動化とAIによる効率化の主要なエンドユーザーです。米国市場の主要企業は、最先端のリーズナブルな価格の検査ソリューションを発売するため、多額の研究開発投資を行っています。医療費と食品安全基準の厳格化も、今後数年間で米国の腸疾患検査市場を拡大すると予想されます。

腸疾患検査市場の動向：

消化器感染症の発生率の上昇

発展途上地域を中心に、衛生環境の欠如、汚染された食品、水による胃腸疾患の発生率の増加、驚くほど高い人口密度により、腸疾患検査の需要が増加しています。2024年のタイムズ・オブ・インディアの記事によると、ベンガルールでは汚染された水源と不十分な衛生環境のために胃腸疾患が増加しています。病気の間はミルクは避けるべきだが、ORSは下痢で脱水症状を起こす危険のある子供には不可欠です。WHOによると、世界中で下痢だけで約150万人が死亡しています。特に開発途上国の5歳未満の子供たちは、下痢、嘔吐、死亡、栄養失調に悩まされています。このことが、腸疾患検査市場の価値をさらに大きく高めています。

政府と規制活動

政府や保健機関が厳格な食品や水の安全基準を導入し、公衆衛生インフラに投資しているため、公衆衛生インフラが増加しています。これは、アウトブレイクを防止し、公衆を保護するための頻繁かつ効果的な腸疾患検査の必要性をさらに煽り、市場をさらに押し上げています。例えば、インド食品安全基準局（FSSAI）は2024年4月、デリー食品安全局と共同で、首都の主要市場を対象とした大規模な意識向上・啓発キャンペーンを開始しました。同様に、NHMはモディ政権下のもう一つの旗艦プログラムであり、医療インフラ、必要不可欠な医薬品と診断薬、草の根レベルの人材能力の開発に取り組んでいます。これらはすべて、患者が地元以外で高額な治療を受ける必要性を減らすことを目的としており、ひいては今後数年間の腸疾患検査市場予測を高めています。

診断技術の大幅な進歩

ポリメラーゼ連鎖反応（PCR）や次世代シークエンシング（NGS）などの分子診断技術の進歩により、腸管感染症は迅速・正確・詳細に検出できるようになりました。市場はさらに急速に拡大しています。例えば、ArcticZymes Technologies（AZT）は2023年8月、新製品であるAZtaqTM DNAポリメラーゼを発表しました。ポリメラーゼ連鎖反応（PCR）アプリケーションで使用される可能性のあるプレミアム耐熱性DNAポリメラーゼは、AZtaqTMと呼ばれています。AZtaqTMは、事業の分子機器ラインの論理的な追加を発表しました。耐熱性DNAポリメラーゼは、PCRにおける重要な酵素であり、多くの分子診断および研究アプリケーションを可能にします。このことは、世界中で腸疾患検査市場の収益をさらに押し上げています。

細菌性腸疾患
- 主な種類
  - C.ディフィシル
  - カンピロバクター症
  - コレラ
  - 大腸菌
  - H.ピロリ菌
  - サルモネラ症
  - 細菌性赤痢
ウイルス性腸疾患
- 主な種類
  - ロタウイルス
  - ノロウイルス
  - その他
寄生虫性腸疾患
- 主な種類
  - アメーバ症
  - クリプトスポリジウム症
  - ジアルジア症

第9章市場内訳：エンドユーザー別

病院診断検査室
独立診断研究所
学術研究機関
その他

第10章市場内訳：地域別

北米
- 米国
- カナダ
アジア太平洋地域
- 中国
- 日本
- インド
- 韓国
- オーストラリア
- インドネシア
- その他
欧州
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- ロシア
- その他
ラテンアメリカ
- ブラジル
- メキシコ
- その他
中東・アフリカ

第11章 SWOT分析

第12章バリューチェーン分析

第13章ポーターのファイブフォース分析

第14章価格分析

第15章競合情勢

市場構造
主要企業
主要企業のプロファイル
- Abbott Laboratories
- BD（Becton, Dickinson and Company）
- Bio-Rad Laboratories Inc.
- Biomerica Inc.
- Biomerieux SA
- Cepheid Inc.（Danaher Corporation）
- Coris BioConcept
- DiaSorin
- Meridian Bioscience Inc.
- Quest Diagnostics

図表

List of Figures

Figure 1: Global: Enteric Disease Testing Market: Major Drivers and Challenges
Figure 2: Global: Enteric Disease Testing Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Enteric Disease Testing Market: Breakup by Product Type (in %), 2024
Figure 4: Global: Enteric Disease Testing Market: Breakup by Technique (in %), 2024
Figure 5: Global: Enteric Disease Testing Market: Breakup by Disease Type (in %), 2024
Figure 6: Global: Enteric Disease Testing Market: Breakup by End User (in %), 2024
Figure 7: Global: Enteric Disease Testing Market: Breakup by Region (in %), 2024
Figure 8: Global: Enteric Disease Testing Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 9: Global: Enteric Disease Testing (Reagents and Consumables) Market: Sales Value (in Million USD), 2019 & 2024
Figure 10: Global: Enteric Disease Testing (Reagents and Consumables) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: Global: Enteric Disease Testing (Equipment) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: Global: Enteric Disease Testing (Equipment) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: Global: Enteric Disease Testing (Molecular Diagnostics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: Enteric Disease Testing (Molecular Diagnostics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: Enteric Disease Testing (Immunodiagnostics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: Enteric Disease Testing (Immunodiagnostics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: Global: Enteric Disease Testing (Bacterial Enteric Disease) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: Global: Enteric Disease Testing (Bacterial Enteric Disease) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: Global: Enteric Disease Testing (Viral Enteric Disease) Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: Global: Enteric Disease Testing (Viral Enteric Disease) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: Global: Enteric Disease Testing (Parasitic Enteric Disease) Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: Global: Enteric Disease Testing (Parasitic Enteric Disease) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: Global: Enteric Disease Testing (Hospital Diagnostic Laboratories) Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: Global: Enteric Disease Testing (Hospital Diagnostic Laboratories) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: Global: Enteric Disease Testing (Independent Diagnostic Laboratories) Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: Global: Enteric Disease Testing (Independent Diagnostic Laboratories) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: Global: Enteric Disease Testing (Academic and Research Institutes) Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: Global: Enteric Disease Testing (Academic and Research Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: Global: Enteric Disease Testing (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: Global: Enteric Disease Testing (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: North America: Enteric Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: North America: Enteric Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: United States: Enteric Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: United States: Enteric Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 35: Canada: Enteric Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 36: Canada: Enteric Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 37: Asia Pacific: Enteric Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 38: Asia Pacific: Enteric Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 39: China: Enteric Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 40: China: Enteric Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 41: Japan: Enteric Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 42: Japan: Enteric Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 43: India: Enteric Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 44: India: Enteric Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 45: South Korea: Enteric Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 46: South Korea: Enteric Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 47: Australia: Enteric Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 48: Australia: Enteric Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 49: Indonesia: Enteric Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 50: Indonesia: Enteric Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 51: Others: Enteric Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 52: Others: Enteric Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 53: Europe: Enteric Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 54: Europe: Enteric Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 55: Germany: Enteric Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 56: Germany: Enteric Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 57: France: Enteric Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 58: France: Enteric Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 59: United Kingdom: Enteric Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 60: United Kingdom: Enteric Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 61: Italy: Enteric Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 62: Italy: Enteric Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 63: Spain: Enteric Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 64: Spain: Enteric Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 65: Russia: Enteric Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 66: Russia: Enteric Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 67: Others: Enteric Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 68: Others: Enteric Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 69: Latin America: Enteric Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 70: Latin America: Enteric Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 71: Brazil: Enteric Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 72: Brazil: Enteric Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 73: Mexico: Enteric Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 74: Mexico: Enteric Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 75: Others: Enteric Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 76: Others: Enteric Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 77: Middle East and Africa: Enteric Disease Testing Market: Sales Value (in Million USD), 2019 & 2024
Figure 78: Middle East and Africa: Enteric Disease Testing Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 79: Global: Enteric Disease Testing Industry: SWOT Analysis
Figure 80: Global: Enteric Disease Testing Industry: Value Chain Analysis
Figure 81: Global: Enteric Disease Testing Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Enteric Disease Testing Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Enteric Disease Testing Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
Table 3: Global: Enteric Disease Testing Market Forecast: Breakup by Technique (in Million USD), 2025-2033
Table 4: Global: Enteric Disease Testing Market Forecast: Breakup by Disease Type (in Million USD), 2025-2033
Table 5: Global: Enteric Disease Testing Market Forecast: Breakup by End User (in Million USD), 2025-2033
Table 6: Global: Enteric Disease Testing Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 7: Global: Enteric Disease Testing Market Structure
Table 8: Global: Enteric Disease Testing Market: Key Players

Product Code: SR112025A2544

The global enteric disease testing market size was valued at USD 4.31 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 5.64 Billion by 2033, exhibiting a CAGR of 2.90% from 2025-2033. Asia Pacific currently dominates the market, holding a market share of over 38.8% in 2024. The enteric disease testing market share is growing due to the increasing incidence of gastrointestinal infections, growing awareness for early diagnosis, advancement in diagnostic technologies, rising demand for faster and accurate testing methods, and increasing global concern for food and water safety standards.

The enteric disease testing market growth is increasing due to the rise of gastrointestinal infections and foodborne diseases and the development of diagnostic technologies. Enteric diseases, caused by bacteria, viruses, and parasites, affect millions worldwide, thereby causing severe diarrhea, dehydration, and other complications. The growth in demand for rapid, accurate, and cost-effective diagnostic solutions is fueling the expansion of the market. Growing awareness about food safety and government initiatives toward disease surveillance coupled with molecular diagnostics such as PCR and immunoassays propel the demand of diagnostic companies, which have begun to invest heavily in faster, more reliable, and quick test solutions, aided by technological upgradation in the healthcare sector. The drive for automation in the laboratory, together with point-of-care testing kits, propels the market ahead. Furthermore, partnerships between research centers and healthcare institutions are making diagnostic products more accessible and available. In addition, increased demand for early and accurate diagnosis will continue to influence the enteric disease testing market trends, an important factor in controlling and preventing outbreaks.

The United States has emerged as a key regional market for enteric disease testing, driven by the increasing cases of foodborne diseases, awareness about gastrointestinal infections, and advances in diagnostic technologies. Molecular diagnostics, which include PCR and immunoassays, are gaining popularity as they are precise and deliver fast results. Government initiatives, for instance, the FDA's Food Safety Modernization Act (FSMA), are further boosting market demand by emphasizing preventive measures and early detection. Hospitals, diagnostic laboratories, and point-of-care testing facilities are major end-users of efficiency through automation and AI in diagnostics. Leading companies in the US market are making significant R&D investments to launch cutting-edge, reasonably priced testing solutions. The cost of health care and the stringency in food safety standards are also expected to increase the U.S. enteric disease testing market over the next few years.

Enteric Disease Testing Market Trends:

Rising Incidence of Gastrointestinal Infections

With the increasing incidence of gastrointestinal diseases due to lack of sanitation, contaminated food, and water, and the alarmingly high population density, mostly in developing regions, the enteric disease testing demand is increasing. Bengaluru has witnessed a rise in gastrointestinal diseases due to tainted water sources and inadequate sanitation, according to a 2024 Times of India story. While milk should be avoided during illnesses, ORS is essential for children who are in danger of dehydration from diarrhea. According to the WHO, about 1.5 Million people die worldwide due to diarrheal disease alone. Children less than 5 years old in developing countries are being especially struck with diarrhea, vomiting, deaths, and malnutrition. This is further increasing the value of the enteric disease testing market substantially.

Government and regulatory activities

Increasing public health infrastructure is growing as the government and health organizations are introducing stringent food and water safety standards and investing in public health infrastructure. This is further fueling the requirement for frequent and effective enteric disease testing to prevent outbreaks and safeguard the public, which is further boosting the market. For instance, the Food Safety and Standards Authority of India (FSSAI) launched a massive awareness and sensitization campaign in April 2024, that covered key markets in the national capital, in association with the Food Safety Department, Delhi. Likewise, the NHM is another flagship program under the Modi government, which deals with the development of health infrastructure, essential drugs and diagnostics, and human resource capabilities at the grassroots level. All these have been aimed at reducing the patient's need for expensive treatments outside their localities, which in turn is enhancing the enteric disease testing market forecast over the coming years.

Significant advancements in diagnostic technologies

Enteric infections may now be detected quickly, accurately, and thoroughly due to advancements in molecular diagnostics such as polymerase chain reaction (PCR) and next-generation sequencing (NGS). The market is expanding more quickly. For instance, ArcticZymes Technologies (AZT) unveiled AZtaqTM DNA Polymerase, a novel product, in August 2023. A premium thermostable DNA polymerase that may be used in polymerase chain reaction (PCR) applications is called AZtaqTM. introduced the AZtaqTM, a logical addition to the business's line of molecular instruments. The thermostable DNA polymerase is a crucial enzyme in PCR that makes many molecular diagnostic and research applications possible. This is further driving the enteric disease testing market revenue across the globe.

Enteric Disease Testing Industry Segmentation:

Analysis by Product Type:

Reagents and Consumables
Equipment

The demand for the reagents and consumables was driven by its need for accurately and efficiently operating diagnostic processes. Repeated testings for pathogens in the gut requires constant stock replenishment for high-quality reagents and consumables. More importantly, rising infectious disease levels and advancements in molecular and rapid testing methods lead to the application of specialized consumables. Increasing governmental grants and the establishment of health infrastructures further promote demand for these core testing supplies. Technological upgrades in the machinery of diagnostic systems, for instance, automated PCR systems, as well as platforms for next-generation sequencing, drive further equipment demands in the market report on enteric disease testing. There is a necessity for high-throughput, reliable, and accurate diagnosis, thereby resulting in an acceptance of highly developed equipment. Additional factors of growing demand include extensive investments in the development of healthcare infrastructure, especially in up-and-coming markets, and investments in laboratory modernization. Additionally, improved disease surveillance programs and public health initiatives boost the market for diagnostic equipment.

Analysis by Technique:

Molecular Diagnostics
Immunodiagnostics

Molecular diagnostics techniques hold the leading position in the market fueled by their high accuracy, sensitivity, and faster turnaround times. These techniques, for example, PCR and next-generation sequencing, permit the accurate detection of a diverse range of pathogens, thus further enhancing disease control and outbreak response. For example, Roche announced the launching of the LightCycler(R) PRO System in November 2023, building on the established gold standard technology of the previous LightCycler(R) Systems. This system is designed to increase performance and usability requirements while connecting translational research with in vitro diagnostics. The LightCycler PRO System further enhances Roche's molecular PCR testing portfolio, which features solutions for different practitioners, from conducting research to testing patients who suffer from cancer, infectious diseases, and many more public health challenges. This is further propelling the demand for enteric disease testing globally.

Analysis by Disease Type:

Bacterial Enteric Disease
- C. Difficile
- Campylobacteriosis
- Cholera
- E. Coli
- H. Pylori
- Salmonellosis
- Shigellosis
Viral Enteric Disease
- Rotavirus
- Norovirus
- Others
Parasitic Enteric Disease
- Amebiasis
- Cryptosporidiosis
- Giardiasis

Bacterial enteric diseases represent the largest segment with a share of 48.0%. The high prevalence of infections such as C. difficile, E. coli, and Salmonellosis creates a significant public health risk and drives the demand for enteric disease testing in bacterial types. Rapid, accurate diagnostics are important for effective treatment, outbreak management, and infection control. Testing demand is also fueled by the association of H. pylori with severe gastrointestinal conditions. The increasing foodborne and waterborne outbreaks, stringent food safety regulations, and the need for efficient healthcare interventions further boost the market for bacterial enteric disease testing.

Analysis by End User:

Hospital Diagnostic Laboratories
Independent Diagnostic Laboratories
Academic and Research Institutes
Others

In the hospital diagnostic laboratory, the need for enteric disease testing arises from the urgent necessity for an accurate diagnosis so that proper patient management and treatment can be assured. High patient volumes and the critical nature of diagnosing gastrointestinal infections require reliable and efficient testing protocols. Independent diagnostic laboratories are in demand due to their specialized services and ability to provide rapid, high-volume testing. They are crucial for routine screening, outbreak management, and offering advanced diagnostic techniques, thus meeting the needs of both healthcare providers and patients. This further creates a positive enteric disease testing market outlook. There is a growing concern in academic and research institutes to study enteric pathogens, develop novel detection techniques, and perform epidemiological research, thereby creating an increased demand. Besides, more funds and grants to infectious disease research organizations increase the demand for high-quality and accurate testing capabilities to support scientific activities and public health.

Regional Analysis:

North America
- United States
- Canada
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

Asia Pacific accounted for a large share of 38.8% for the enteric disease testing market, driven by the increasing incidence rates of gastrointestinal infections due to poor sanitation and hygiene. Rotavirus, Cryptosporidium spp., enterotoxigenic Escherichia coli (ETEC), and Shigella spp. are the primary causes of diarrheal illnesses and deaths, according to new data from the Global Enteric Multicenter Study (GEMS) on the burden and etiology of diarrhea among children living in developing nations. Moreover, norovirus infections, which equally affect adults and children, are the primary source of foodborne disease outbreaks and are responsible for 20% of diarrheal diseases. Consequently, rising awareness about health problems, increasing government efforts in controlling diseases, and better health infrastructure also spur demand. Improved diagnostics and an increased incidence of food and water-borne diseases fuel the growth of the market further. Rapid urbanization and the expanding middle-class population base, with greater access to healthcare, are contributing to the market growth.

The market for North American enteric disease testing is stimulated by strong healthcare infrastructure, advanced diagnostic technologies, and stringent food safety regulations. The CDC and the FDA play a crucial role in disease surveillance and prevention, enforcing strict food and water safety standards. Saliently, the staggering prevalence rates of foodborne illnesses, including Salmonella and Norovirus, drive demand for quick diagnostics. Molecular diagnostics, automation, and AI-based testing are revolutionizing the market. Increased R&D investment along with initiatives of the FDA, such as FSMA, are factors broadening the market's expansion.

The enteric disease testing market in Europe is also expected to grow through stringent food safety laws of the EFSA and rapidly increasing foodborne illness outbreaks. High usage of molecular diagnostics and point-of-care testing is driving the growth of the market. Countries like Germany, the UK, and France are highly investing in diagnostic innovations, improving the efficiency of testing. With the increasing organic and processed food demand, the concern over contamination has increased the demand for rapid and high throughput testing solutions across clinical and food safety sectors.

The Latin American enteric disease testing market is growing due to the rise in foodborne illness cases and the increase in healthcare investments. Poor sanitation conditions and limited water availability are commonly found in numerous regions, increasing the risk for frequent outbreaks due to cholera, E. coli, or rotavirus infection. Governments undertake public health projects, enhance regulatory food safety, and strengthen disease surveillance. Moreover, the growth in private diagnostic laboratory facilities and more affordable rapid-testing kits is creating an opportunity in enteric disease diagnostics, more so in such countries as Brazil, Mexico, and Argentina, as their healthcare is rapidly changing.

In the Middle East and Africa, enteric disease testing demand is increasing due to a high burden of waterborne and foodborne illnesses linked to poor sanitation, contaminated water, and inadequate healthcare access. Diarrheal diseases are a leading cause of mortality, especially in children. Governments and international organizations are focusing on improving disease detection through public health programs and expanded laboratory networks. Growing urbanization, increasing food imports, and significant investments in the healthcare infrastructure further fuel the utilization of modern diagnostic techniques, primarily in Saudi Arabia, South Africa, and the UAE.

Key Regional Takeaways:

United States Enteric Disease Testing Market Analysis

In 2024, the United States held a share of 90.0% of the enteric disease testing market in North America due to emerging outbreaks of foodborne illnesses, a strict regulatory framework, and consumer awareness. According to the Centers for Disease Control and Prevention, millions of infections are produced annually due to foodborne pathogens like Salmonella, E. coli, and Norovirus, and therefore there is a need for sophisticated diagnostic solutions. According to the CDC, each year about 1 in 6 Americans (or 48 Million people) gets sick, 128,000 are hospitalized, and 3,000 die of foodborne diseases. Moreover, the FDA and the USDA have made strict compliance with food safety regulations, and the demand for rapid, accurate testing technologies, including PCR-based and immunoassay methods, is rising. In addition to this, multiplex molecular diagnostics are adopted in increasing numbers with the possibility of detecting more than one pathogen simultaneously at a high specificity. Technology advances, like NGS, improve the identification of pathogens, especially in surveillance and outbreak management. Point-of-care testing is expanding with improvements in early detection in healthcare settings and remote locations. Further, the increasing emergence of antimicrobial-resistant bacteria is motivating more investment in new diagnostic platforms and promoting private-public partnerships between companies, research organizations, and government agencies. Higher healthcare expenditure and insurance coverage for diagnostic testing facilitate early screening and thus contribute to market growth. Additionally, the growing demand for at-home test kits due to e-commerce expansion is shaping the market landscape.

Europe Enteric Disease Testing Market Analysis

Europe's enteric disease testing market is driven by stringent food safety laws, technological advancements, and high public health awareness. The European Food Safety Authority has strict regulations over microbial contamination in food and water, forcing manufacturers and healthcare facilities to employ rapid and reliable diagnostic methods. The increased surveillance of zoonotic diseases and antimicrobial resistance has led to a surge in demand for advanced molecular and immunological testing platforms. Salmonella was the causative agent linked to the highest multi-country foodborne outbreaks reported in the European Union in 2023, at 17 foodborne outbreaks, 81.0% of the total for multi-country foodborne outbreaks, according to the European Union One Health 2023 Zoonoses report. Besides this, the region is experiencing tremendous growth in automated laboratory systems and next-generation sequencing (NGS) techniques, allowing for the accurate identification of enteric pathogens. The increasing number of foodborne infections due to imported food products has enhanced the demand for real-time PCR and multiplex diagnostic assays. Public-private partnerships and European Union-funded projects are promoting research into innovative diagnostic solutions, which in turn is further fueling the growth of the market. Additionally, the growing incidence of traveler's diarrhea, especially due to tourism within and outside the region, is enhancing the demand for portable and rapid testing solutions. In addition, advancing point-of-care diagnostics, integrated with AI-driven data analytics for tracking the disease, also enhances the efficiency of outbreak responses. The market also contributes to the rising integration of diagnostic labs with digital health platforms, improving test access and turnaround time.

Asia Pacific Enteric Disease Testing Market Analysis

Asia Pacific's enteric disease testing market is being propelled by increasing disease burden, rapid urbanization, and improvements in healthcare infrastructure. The region experiences high rates of waterborne and foodborne infections on account of inadequate sanitation and contaminated drinking water. According to studies, an estimated 37.7 Million Indians suffer from waterborne illnesses each year. Salmonella, Vibrio cholerae, rotavirus, and Shigella are still among the major pathogens, and thus, governing agencies are taking measures to strengthen surveillance programs and invest in advanced diagnostic technologies. In addition to this, increasing investments in healthcare, especially in China, India, and Southeast Asian countries, are helping the adoption of automated diagnostic systems for enteric pathogens. The growth rate of the market is being fueled by increasing private laboratories and multinational diagnostic companies, as the PCR-based, ELISA, and microarray platforms are also becoming popular, as they show high accuracy along with rapid results. In addition, technological progress in molecular diagnostics and increased point-of-care testing are making faster and more accurate detection possible. Favorable government initiatives, including India's National Health Mission and China's CDC initiatives, will encourage routine screening. The rising incidence of antimicrobial resistance and emerging zoonotic pathogens are also motivating the development of rapid diagnostic tools, especially in the context of food safety regulations and outbreak response mechanisms.

Latin America Enteric Disease Testing Market Analysis

Latin America's enteric disease testing market is growing owing to frequent waterborne disease outbreaks, improving healthcare infrastructure, and rising government initiatives. Many countries face challenges with unsafe drinking water and inadequate sanitation, leading to high incidence rates of cholera, Shigella, and rotavirus infections. There were around 24,200 suspected cholera cases as of 17 January 2023, as reported in the Latin America & The Caribbean Weekly Situation Update. The region's governing agencies are largely increasing investments in surveillance programs and expanding diagnostic capacities, especially in Brazil, Mexico, and Argentina. In addition, emerging private diagnostic laboratories and collaborations with major global diagnostic firms continue to improve testing availability. Point-of-care and rapid molecular testing technologies are becoming more prevalent, especially in outlying and less privileged regions. Further demand for dependable diagnostic solutions is coming from further strengthened regulations related to food and beverage safety along with increased awareness about antimicrobial resistance. The expansion of public health insurance programs and international funding of infectious disease control are also in support of this market growth.

Middle East and Africa Enteric Disease Testing Market Analysis

The Middle East and Africa's enteric disease testing market is growing due to high disease prevalence, increasing government healthcare spending, and improvements in diagnostic capabilities. Reports indicate that the healthcare expenditure in the Gulf Cooperation Council (GCC) is estimated to be at USD 135.5 Billion by 2027. Water contamination, poor sanitation, and climate-related factors contribute to persistent outbreaks of Cholera, Typhoid fever, and Norovirus. Governments and non-governmental organizations (NGOs) are intensifying efforts to improve water quality and expand disease surveillance programs. Moreover, the adoption of rapid diagnostic kits, particularly in regions with limited laboratory infrastructure, is enhancing early disease detection. Investments in centralized laboratory networks and mobile diagnostic units are improving accessibility in remote areas. In addition to the above, with isothermal amplification-based tests, the advantage of cost and reliability in resource-poor environments is making such technologies more relevant. International partnerships with WHO and UNICEF for infectious diseases are also fueling the need for efficient solutions in enteric disease testing.

Competitive Landscape:

The competition in the market for enteric disease testing is highly competitive, wherein the key market players are concentrated on technological advances, strategic collaboration, and geographically expanding markets to strengthen market presence. Major companies such as bioMerieux, Thermo Fisher Scientific, BD, and Abbott are investing heavily in molecular diagnostics, automation, and AI-driven solutions to improve test accuracy and efficiency. One of the significant trends is the development of rapid and point-of-care testing kits, which allows quicker diagnosis and treatment, especially in resource-limited settings. Companies are also integrating next-generation sequencing (NGS) and PCR-based diagnostics to enhance detection capabilities. The market is being shaped by strategic mergers and acquisitions, such as partnerships between diagnostic firms and government agencies to improve disease surveillance. Increasing focus on sustainability and affordability is driving innovation in cost-effective diagnostic solutions, making it more accessible in emerging markets. These efforts are creating a positive enteric disease testing market outlook.

The report provides a comprehensive analysis of the competitive landscape in the enteric disease testing market with detailed profiles of all major companies, including:

Abbott Laboratories
BD (Becton, Dickinson and Company)
Bio-Rad Laboratories Inc.
Biomerica Inc.
Biomerieux SA
Cepheid Inc. (Danaher Corporation)
Coris BioConcept
DiaSorin
Meridian Bioscience Inc.
Quest Diagnostics

Key Questions Answered in This Report

1.How big is the enteric disease testing market?
2.What is the future outlook of enteric disease testing market?
3.What are the key factors driving the enteric disease testing market?
4.Which region accounts for the largest enteric disease testing market share?
5.Which are the leading companies in the global enteric disease testing market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Enteric Disease Testing Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product Type

6.1 Reagents and Consumables
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Equipment
- 6.2.1 Market Trends
- 6.2.2 Market Forecast

7 Market Breakup by Technique

7.1 Molecular Diagnostics
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Immunodiagnostics
- 7.2.1 Market Trends
- 7.2.2 Market Forecast

8 Market Breakup by Disease Type

8.1 Bacterial Enteric Disease
- 8.1.1 Market Trends
- 8.1.2 Major Types
  - 8.1.2.1 C. Difficile
  - 8.1.2.2 Campylobacteriosis
  - 8.1.2.3 Cholera
  - 8.1.2.4 E. Coli
  - 8.1.2.5 H. Pylori
  - 8.1.2.6 Salmonellosis
  - 8.1.2.7 Shigellosis
- 8.1.3 Market Forecast
8.2 Viral Enteric Disease
- 8.2.1 Market Trends
- 8.2.2 Major Types
  - 8.2.2.1 Rotavirus
  - 8.2.2.2 Norovirus
  - 8.2.2.3 Others
- 8.2.3 Market Forecast
8.3 Parasitic Enteric Disease
- 8.3.1 Market Trends
- 8.3.2 Major Types
  - 8.3.2.1 Amebiasis
  - 8.3.2.2 Cryptosporidiosis
  - 8.3.2.3 Giardiasis
- 8.3.3 Market Forecast

9 Market Breakup by End User

9.1 Hospital Diagnostic Laboratories
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Independent Diagnostic Laboratories
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Academic and Research Institutes
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
9.4 Others
- 9.4.1 Market Trends
- 9.4.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 Abbott Laboratories
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
  - 15.3.1.3 Financials
  - 15.3.1.4 SWOT Analysis
- 15.3.2 BD (Becton, Dickinson and Company)
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
  - 15.3.2.3 Financials
  - 15.3.2.4 SWOT Analysis
- 15.3.3 Bio-Rad Laboratories Inc.
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
  - 15.3.3.3 Financials
  - 15.3.3.4 SWOT Analysis
- 15.3.4 Biomerica Inc.
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
  - 15.3.4.3 Financials
  - 15.3.4.4 SWOT Analysis
- 15.3.5 Biomerieux SA
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
  - 15.3.5.3 Financials
  - 15.3.5.4 SWOT Analysis
- 15.3.6 Cepheid Inc. (Danaher Corporation)
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
  - 15.3.6.3 SWOT Analysis
- 15.3.7 Coris BioConcept
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
- 15.3.8 DiaSorin
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
  - 15.3.8.3 Financials
  - 15.3.8.4 SWOT Analysis
- 15.3.9 Meridian Bioscience Inc.
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
  - 15.3.9.3 Financials
  - 15.3.9.4 SWOT Analysis
- 15.3.10 Quest Diagnostics
  - 15.3.10.1 Company Overview
  - 15.3.10.2 Product Portfolio
  - 15.3.10.3 Financials
  - 15.3.10.4 SWOT Analysis

腸疾患検査の市場規模、シェア、動向、予測：製品タイプ、手法、疾患タイプ、エンドユーザー、地域別、2025～2033年

Enteric Disease Testing Market Size, Share, Trends and Forecast by Product Type, Technique, Disease Type, End User, and Region, 2025-2033

腸疾患検査市場の動向：

目次

第1章 序文

第2章 調査範囲と調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界の腸疾患検査市場

第6章 市場内訳：製品タイプ別

第7章 市場内訳：手法別

第8章 市場内訳：疾患タイプ別

第9章 市場内訳：エンドユーザー別

第10章 市場内訳：地域別